Central nervous system manifestations of COVID-19: A systematic review

Good article in the Journal of the Neurological Sciences June 16, 2020 In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19. Results Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications […]

Alert (AA22-103A)

Contact Information
All organizations should report incidents and anomalous activity to CISA 24/7 Operations Center at [email protected] or (888) 282-0870 and/or to the FBI via your local FBI field office or the FBI’s 24/7 CyWatch at (855) 292-3937 or [email protected] When available, please include the following information regarding the incident: date, time, and location of the incident; type of activity; number of people affected; type of equipment used for the activity; the name of the submitting company or organization; and a designated point of contact. For NSA client requirements or general cybersecurity inquiries, contact the Cybersecurity Requirements Center at 410-854-4200 or [email protected]

CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies

CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease Decision Follows Robust Stakeholder Input and Creates Pathway for Enhanced Access and Coverage of Drugs that Receive Traditional FDA Approval Treatment for Alzheimer’s Disease Today, the Centers for Medicare & Medicaid Services (CMS) released a national policy for […]

CMS Returning to Certain Pre-COVID-19 Policies for Long-term Care

CMS Returning to Certain Pre-COVID-19 Policies in Long-term Care and Other Facilities  Actions continue to protect the health and safety of nursing home residents The Centers for Medicare & Medicaid Services (CMS) is taking steps to continue to protect nursing home residents’ health and safety by announcing guidance that restores certain minimum standards for compliance […]

Sotrovimab Monoclonal Antibody Treatment for COVID-19

As of April 5, 2022, the U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for GSK-Vir Biotechnology’s sotrovimab monoclonal antibody treatment. It is important to note Sotrovimab is no longer authorized for use within the U. S. The full FDA press release can be read at FDA updates Sotrovimab emergency use […]

Patterns of Potential Moral Injury in Post-9/11 Combat Veterans and COVID-19 Healthcare Workers

“Moral injury has been defined as the “psychological, biological, spiritual, behavioral and social impact of perpetrating, failing to prevent, or bearing witness to acts that transgress deeply held moral beliefs and expectations.”1 Since this definition was introduced in 2009, the subsequent decade of research focused almost exclusively on military veterans. Among military personnel, the killing of […]

Community fights to save Alzheimer’s care home

Now we are starting to see nursing homes and assisted living facilities struggle to pay their bills.  Many are being forced to sell to larger investment companies or just going out of business.  This is only the beginning, there was a great article published by the Honolulu Advertiser today.  I think this will be our […]

New Recommendations for Use of 15-Valent and 20-Valent Pneumococcal Conjugant Vaccine, 2022

What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by age and risk groups. What is added by this report? On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent PCV (PCV15) or […]

Get free at-⁠home COVID-⁠19 tests

It’s time to order you free COVID-19 tests.  Key things to remember is: If you are symptomatic, and your rapid test is negative you should follow it up with a PCR test. Rapid tests have a harder time picking up Omicron. When in doubt get advice from your physician. Get vaccinated now don’t wait until […]

Vestex Scrubs might be able to protect you from taking COVID-19 home

FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims […]

VESTEX Scrubs, T-shirts and Jackets to protect you from fluid, bacteria, and viruses.

Don’t risk taking body fluids, bacteria or viruses home anymore.   VESTEX is the company to go to.  They are approved by the FDA and work the way advertise.  They are worth every penny. Tried, Tested and Loved. The global VESTEX® brand franchise has been in development for over a decade. For thousands of consumers around the […]

Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination

Memo # QSO-22-07-ALL Posting Date 2021-12-28 Fiscal Year 2022 Summary CMS is committed to ensuring America’s healthcare facilities respond effectively in an evidence-based way to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE). •On November 05, 2021, CMS published an interim final rule with comment period (IFC). This rule establishes requirements regarding COVID-19 vaccine […]

NIOSH-approved N95 Particulate Filtering Facepiece Respirators

For a list of approved N95 mask visit the link below don’t buy counterfeit masks. This list is reviewed and updated weekly. Manufacturers Listed from A to Z – 3M The N95 respirator is the most common of the seven types of particulate filtering facepiece respirators. This product filters at least 95% of airborne particles […]